Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine

Immunotherapy
John StanfordChristina Bogue

Abstract

Immunotherapy with Mycobacterium vaccae has been shown to be beneficial as part of the treatment for a wide range of diseases. In the respiratory system, the late airway response in bronchial asthma is modified by a single dose and bronchial aspects of hayfever are reduced allowing a major reduction in the use of bronchial dilators. In studies of advanced adenocarcinoma of the lung survival is increased by an average of 4 months when up to five doses of M. vaccae are added to the course of chemotherapy. The quality of life of cancer patients receiving immunotherapy with M. vaccae is improved, even if survival is not increased. It is suggested that the mechanism of action of immunotherapy with heat-killed, borate-buffered M. vaccae is likely to be very similar in all these diseases for which human pulmonary tuberculosis provides a model. In this study, additional immunological data are reported from material stored from an earlier study of immunotherapy for pulmonary tuberculosis to help complete the information on the way that treatment with three monthly injections of heat-killed, borate-buffered M. vaccae (SRL172) may act.

References

May 1, 1995·Clinical and Experimental Immunology·J S FriedlandG E Griffin
Jan 1, 1995·Immunology Today·M A Cassatella
May 1, 1996·The Journal of Experimental Medicine·S NicholsonJ L Ho
Mar 28, 1998·American Journal of Respiratory and Critical Care Medicine·R CondosN W Schluger
Jul 10, 1998·FEMS Immunology and Medical Microbiology·A LehrerJ Stanford
Jan 1, 1997·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·E A RichZ Toossi
Feb 13, 2001·Scandinavian Journal of Immunology·J O OloboS Britton
Mar 13, 2001·Annual Review of Immunology·J L Flynn, J Chan
Aug 30, 2001·Science Progress·J L StanfordJ M Grange
Dec 26, 2001·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·G StansbyJ L Stanford
Feb 28, 2002·Annual Review of Immunology·Jean-Laurent Casanova, Laurent Abel
Feb 4, 2003·Nature Reviews. Immunology·Giorgio Trinchieri
Mar 1, 2003·The European Respiratory Journal·L CamporotaR Djukanovic
Apr 18, 2003·Clinical and Experimental Immunology·G MazzarellaA Sanduzzi
Jan 15, 2004·Trends in Molecular Medicine·Ramireddy Bommireddy, Thomas Doetschman

❮ Previous
Next ❯

Citations

Apr 15, 2014·Vaccine·Matthias I GröschelTjip S van der Werf
May 19, 2020·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Abu Salim Mustafa

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
ELISA
bronchoalveolar
lavage

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Immunobiology
Graham A W RookL Rosa Brunet
Proceedings of the National Academy of Sciences of the United States of America
Roland BroschS T Cole
Canadian Journal of Microbiology
Pradeep Reddy MarriG Brian Golding
© 2021 Meta ULC. All rights reserved